2020
Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials
Bikdeli B, Chatterjee S, Kirtane AJ, Parikh SA, Andreozzi GM, Desai NR, Francese DP, Gibson CM, Piazza G, Goldhaber SZ, Eikelboom JW, Krumholz HM, Stone GW. Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials. Seminars In Thrombosis And Hemostasis 2020, 46: 908-918. PMID: 33086402, DOI: 10.1055/s-0040-1716874.Peer-Reviewed Original ResearchConceptsDeep vein thrombosisUse of sulodexideCause mortalityCardiovascular mortalityReduced oddsPulmonary embolismOdds ratioOdds of VTESafety of sulodexideCardiovascular risk factorsCochrane Central RegisterPeripheral arterial diseaseHistory of MIThrombotic cardiovascular diseasesRandom-effects modelCardiovascular efficacyOral glycosaminoglycansCardiovascular outcomesHemorrhagic eventsCentral RegisterVein thrombosisControlled TrialsArterial diseaseRandomized trialsRisk factors
2010
Hospital Volume and 30-Day Mortality for Three Common Medical Conditions
Ross JS, Normand SL, Wang Y, Ko DT, Chen J, Drye EE, Keenan PS, Lichtman JH, Bueno H, Schreiner GC, Krumholz HM. Hospital Volume and 30-Day Mortality for Three Common Medical Conditions. New England Journal Of Medicine 2010, 362: 1110-1118. PMID: 20335587, PMCID: PMC2880468, DOI: 10.1056/nejmsa0907130.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionHospital volumeHeart failureMyocardial infarctionVolume thresholdRisk factorsAnnual hospital volumeHigh-volume hospitalsPatient risk factorsOdds of deathCommon medical conditionsAcute care hospitalsMedicare administrative claimsHierarchical logistic regression modelsCross-sectional analysisLogistic regression modelsCare hospitalHospital characteristicsReduced oddsMedical conditionsAdministrative claimsInfarctionPatientsPneumoniaService beneficiaries